Nasdaq
IMDX
Insight Molecular Diagnostics Inc.
- Health Care
- 1 day
- −4.0%
- 1 month
- −2.6%
- 1 year
- +81.1%
$4.80 · Mkt cap $155M
At the 6 Aug 2026 close
Nasdaq
Insight Molecular Diagnostics Inc.
$4.80 · Mkt cap $155M
At the 6 Aug 2026 close
Insight Molecular Diagnostics Inc. trades under the ticker IMDX on Nasdaq, in the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances). Its market capitalisation is $155M. The last closing price was $4.80, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +81.1%, and −2.6% over the past month. Returns are price returns and exclude dividends.
This page exists because IMDX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.